0001004878-17-000050.txt : 20170228 0001004878-17-000050.hdr.sgml : 20170228 20170227200924 ACCESSION NUMBER: 0001004878-17-000050 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170228 DATE AS OF CHANGE: 20170227 EFFECTIVENESS DATE: 20170228 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CEL SCI CORP CENTRAL INDEX KEY: 0000725363 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 840916344 STATE OF INCORPORATION: CO FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-281426 FILM NUMBER: 17644298 BUSINESS ADDRESS: STREET 1: 8229 BOONE BLVD . STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 BUSINESS PHONE: 7035069460 MAIL ADDRESS: STREET 1: 8229 BOONE BLVD. STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 FORMER COMPANY: FORMER CONFORMED NAME: INTERLEUKIN 2 INC DATE OF NAME CHANGE: 19880317 D 1 primary_doc.xml X0707 D LIVE 0000725363 CEL SCI CORP 8229 BOONE BLVD . SUITE 802 VIENNA VA VIRGINIA 22182 7035069460 COLORADO INTERLEUKIN 2 INC Corporation true Geert R. Kersten 8229 Boone Blvd. Suite 802 Vienna VA VIRGINIA 22182 Executive Officer Director Patricia B. Prichep 8229 Boone Blvd. Suite 802 Vienna VA VIRGINIA 22182 Executive Officer Eyal Talor 8229 Boone Blvd. Suite 802 Vienna VA VIRGINIA 22182 Executive Officer Daniel H. Zimmerman 8229 Boone Blvd. Suite 802 Vienna VA VIRGINIA 22182 Executive Officer John Cipriano 8229 Boone Blvd. Suite 802 Vienna VA VIRGINIA 22182 Executive Officer Alexander G. Esterhazy 20 Chemin du Pre-Poiset CH-1253 Vandoeuvres Geneve V8 SWITZERLAND 00000 Director Peter R. Young 208 Hewitt Drive Suite 103-143 Waco TX TEXAS 76712 Director Bruno Baillavoine 8229 Boone Blvd. Suite 802 Vienna VA VIRGINIA 22182 Director Pharmaceuticals $1 - $1,000,000 06b false 2017-02-16 false true true false 1000 N/A None H.C. Wainwright & Co., LLC 375 430 Park Avenue New York NY NEW YORK 10022 All States false 1000000 1000000 0 false 2 70000 0 142000 true false CEL SCI CORP /s/ Geert R. Kersten Geert R. Kersten Chief Executive Officer 2017-02-27